Francisco, Lyka D.

HRN: 22-45-57  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
05/26/2023
06/02/2023
IVTT
600mg As LD Then 300mg As MD
Q24
Candidiasis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: